XML 31 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2019
Jul. 31, 2018
Cash flows from operating activities:    
Net loss $ (114,354) $ (307,401)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 24,261 15,681
Amortization of deferred contract acquisition and fulfillment costs 31,149 19,146
Amortization of debt discount and transaction costs 13,002 0
Non-cash operating lease costs 8,863  
Stock-based compensation expense 98,063 309,959
Deferred income taxes 28 (12)
Other (2,371) (875)
Changes in operating assets and liabilities    
Accounts receivable 35,896 15,385
Contract assets (4,905) 1,149
Prepaid expenses and other current assets (3,157) (3,406)
Deferred contract acquisition and fulfillment costs (48,439) (30,339)
Other assets 959 1,335
Accounts payable 1,588 (5,034)
Accrued expenses 12,439 2,306
Accrued compensation 2,427 360
Contract liabilities 21,746 19,503
Operating lease liabilities (7,198) 0
Other liabilities 2,063 (69)
Net cash provided by operating activities 72,060 37,688
Cash flows from investing activities:    
Purchases of marketable securities (530,886) 0
Maturities of marketable securities 244,449 0
Purchases of strategic investments (15,500) 0
Purchases of property and equipment (29,791) (10,520)
Net cash used in investing activities (331,728) (10,520)
Cash flows from financing activities:    
Proceeds from issuance of common stock in initial public offering, net of underwriting commissions 0 529,305
Proceeds from issuance of common stock in initial public offering, net of underwriting commissions (85,978) 0
Payment of tax withholding obligation on RSU settlement 42,448 10,318
Proceeds from exercise of stock options 10,563 0
Payment of deferred offering costs 0 (3,522)
Net cash provided by (used in) financing activities (32,967) 536,101
Effect of foreign exchange on cash, cash equivalents and restricted cash (1,120) (1,543)
Net increase (decrease) in cash, cash equivalents and restricted cash (293,755) 561,726
Cash, cash equivalents and restricted cash at beginning of period 518,178 257,436
Cash, cash equivalents and restricted cash at end of period 224,423 819,162
Supplemental disclosure:    
Cash paid for interest 1,414 204
Cash paid for operating lease liabilities 10,984  
Cash paid for taxes 1,109 2,001
Non-cash investing and financing activities:    
Property and equipment in accounts payable and other accrued liabilities 4,046 2,100
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering 0 547,854
Conversion of preferred stock warrant to common stock warrant in connection with initial public offering 0 848
Preferred stock accretion 0 353
Deferred offering costs accrued and unpaid 0 $ 169
Operating lease right-of-use assets exchanged for lease obligations 53,754  
Derecognition of build-to-suit lease $ 2,479